RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
  Bone Cancer
  Breast Cancer
  Cervical Cancer
  Gastric Cancer
  Liver Cancer
  Nerve Tissue
  Ovarian Cancer
  Pancreatic Cancer
  Prostate Cancer
  Rectal Cancer
  Renal Cell Carcinoma
  Risk Factors
  Testicular Cancer
 Clinical Trials
 Infectious Diseases
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Colon Channel

subscribe to Colon newsletter
Latest Research : Cancer : Colon

   EMAIL   |   PRINT
Major Colorectal Cancer Screening Study Enters Last Phase of Recruitment

Apr 20, 2005 - 7:46:00 PM
"This study will provide important data on the performance of this new test and will allow us to determine its value as a potential screening method."

[RxPG] Having recently enrolled the 4,000th study participant, researchers want to emphasize that there is still an opportunity for an additional 400 people to participate in this trial before recruitment stops at the end of May.

Mayo Clinic continues to successfully enroll men and women in a large colorectal screening clinical trial. Mayo is the lead medical center and is one of 34 sites in the United States that is participating in this research project.

Launched in October 2001 and sponsored by the National Cancer Institute (NCI), this research study seeks to enroll healthy men and women between the ages of 65 and 80 who have not been screened for colorectal cancer within the past 10 years. This trial is attempting to compare a non invasive DNA-based stool test against colonoscopy, which is the accepted standard for colorectal cancer screening.

Colorectal cancer is one of the most common cancers in the United States, affecting one in every 17 persons. Death rates from colorectal cancer are second only to lung cancer deaths in the United States. It occurs with equal frequency in men and women and is most often found among people who are over age 50.
The toll in terms of suffering, lost productivity, and cost is enormous but colorectal cancer is preventable with screening.

Multiple medical societies, including the American Cancer Society, recommend regular screening after age 50, but less than one-third of Americans have ever been screened. Barriers to screening have included lack of awareness, inconsistent insurance coverage by third parties, and patient fear or non acceptance of the screening intervention.

"In our study, funded by the National Cancer Institute, we are evaluating a promising new DNA-based stool test that requires no bowel preparation or diet restriction," said David Ahlquist, M.D., a Mayo gastroenterologist and the national study chair. "This study will provide important data on the performance of this new test and will allow us to determine its value as a potential screening method."

Publication: Mayo Clinic
On the web: www.mayoclinic.com 

Advertise in this space for $10 per month. Contact us today.

Related Colon News
Screening for colon cancer depends on location, race and ethnicity
Alcohol, cigarettes can cause bowel cancer
TSPAN1 expression-a useful tool to evaluate prognosis in colorectal cancer
Advances in screening and markers improve early detection of colorectal cancer
Rice bran can reduce the risk of intestinal cancer
Simutaneous removal of primary and liver metastasis favourable in some colorectal cancer patients
Follow-up endoscopic surveillance in colorectal cancer patients improves survival
Researchers identify cell pathway which plays a critical role in the development of colon cancer
Regular aerobics protects men from colon cancer
Role for MicroRNAs in Oxygenation, Nourishing of Colon Tumors

Subscribe to Colon Newsletter

Enter your email address:

 Additional information about the news article
Being a participant in this research study would involve collection of three stool samples, a blood draw and a colonoscopy procedure. Colonoscopy is most accurate approach used to detect colorectal cancers at this time. A colonoscopy is needed in this study for comparison in determining the accuracy of the stool DNA test.
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)